Kim Lorence H.

Average Profitability
5.12%
Insider Buys Quantity
1
Insider Buys Sum
$1M
Insider Sells Quantity
15
Insider Sells Sum
$70.39M

Insider Activity of Kim Lorence H.

The largest purchase of all time was on 2022-07-22 and amounted to 50000 shares of Revolution Medicines, Inc. for $1M.

The largest sale of all time was on 2020-05-18 and amounted to 241000 shares of Moderna, Inc. for $19.79M.

Biography of Kim Lorence H.

No biography is available at this moment.

2022-07-22PurchaseRevolution Medicines, Inc.
RVMD
50,000
0.0528%
$20.00$1M+5.12%
2020-06-02SaleModerna, Inc.
MRNA
Chief Financial Officer
241,000
0.0848%
$58.30$14.05M+83.99%
2020-05-27SaleModerna, Inc.
MRNA
Chief Financial Officer
241,000
0.0744%
$51.13$12.32M+93.62%
2020-05-18SaleModerna, Inc.
MRNA
Chief Financial Officer
241,000
0.1194%
$82.12$19.79M+13.85%
2020-05-15SaleModerna, Inc.
MRNA
Chief Financial Officer
2,600
0.001%
$63.80$165,880+33.29%
2020-05-12SaleModerna, Inc.
MRNA
Chief Financial Officer
241,000
0.0938%
$64.49$15.54M+33.04%
2020-04-15SaleModerna, Inc.
MRNA
Chief Financial Officer
20,000
0.0044%
$36.21$724,230+102.2%
2020-03-16SaleModerna, Inc.
MRNA
Chief Financial Officer
20,000
0.0032%
$26.19$523,819+167.65%
2020-03-04SaleModerna, Inc.
MRNA
Chief Financial Officer
20,000
0.0033%
$27.71$554,200+155.13%
2020-02-26SaleModerna, Inc.
MRNA
Chief Financial Officer
18,652
0.0032%
$28.59$533,267+138.41%
2020-02-25SaleModerna, Inc.
MRNA
Chief Financial Officer
1,348
0.0002%
$25.63$34,550+192.38%
2020-02-07SaleModerna, Inc.
MRNA
Chief Financial Officer
33,295
0.0046%
$23.06$767,783+192.13%
2020-01-28SaleModerna, Inc.
MRNA
Chief Financial Officer
900
0.0001%
$23.37$21,033+199.87%
2020-01-27SaleModerna, Inc.
MRNA
Chief Financial Officer
23,805
0.0033%
$23.01$547,753+194.77%
2020-01-22SaleModerna, Inc.
MRNA
Chief Financial Officer
2,000
0.0003%
$23.04$46,080+203.55%
2019-12-06SaleModerna, Inc.
MRNA
Chief Financial Officer
238,532
0.0288%
$20.00$4.77M+225.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.